Published in Life Sci on August 01, 1969
Some neurochemical effects of amphetamine, methylamphetamine and p-bromomethylamphetamine in the rat. Br J Pharmacol (1971) 1.14
Effects of chronic (+/-)-propranolol on catecholamines and GABA in rat striatum [proceedings]. Br J Pharmacol (1977) 0.87
Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels. Br J Pharmacol (1974) 0.76
Effect of p-nitromethylamphetamine on biogenic amines and their amino-acid precursors in rat brain. Br J Pharmacol (1971) 0.75
Permanent alterations in catecholamine concentrations in discrete areas of brain in the offspring of rats treated with methylamphetamine and chlorpromazine. Br J Pharmacol (1973) 0.75
Some effects of the hallucinogenic drug 2,5-dimethoxy-4-methylamphetamine on the metabolism of biogenic amines in the rat brain. Br J Pharmacol (1972) 0.75
Social isolation in the young rat: neurochemical correlates of chronic amphetamine treatment. Ir J Med Sci (1978) 0.75
Some neuropharmacological aspects of schizophrenia: a short review. Ir J Med Sci (1978) 0.75
Suggestions on the pharmacological actions of ethinyloestradiol and progesterone on the control of monoamine metabolism in three regions from the brains of gonadectomized male and female mice and the possible clinical significance. Arch Int Pharmacodyn Ther (1974) 1.71
The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther (1997) 1.61
The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.44
Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci (1998) 1.44
Social isolation in the young rat: neurochemical effects of treatment with a long-acting neuroleptic, alpha-flupenthixol decanoate [proceedings]. Br J Pharmacol (1978) 1.38
Safety of amoxapine. Lancet (1989) 1.37
A non-invasive instrument for clinical assessment of the pre-corneal tear film stability. Curr Eye Res (1985) 1.27
Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain. Psychopharmacologia (1974) 1.26
Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry (2009) 1.16
Rodent models of alcoholism: a review. Alcohol Alcohol (1989) 1.14
Some neurochemical effects of amphetamine, methylamphetamine and p-bromomethylamphetamine in the rat. Br J Pharmacol (1971) 1.14
Changes in brain monoamine concentrations during the oestrous cycle in the mouse: possible pharmacological implications. J Pharm Pharmacol (1971) 1.06
Effect of fluorescein instillation on the pre-corneal tear film stability. Curr Eye Res (1985) 1.05
An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience (1998) 1.03
Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. Pharmacol Ther (1990) 1.00
The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain. Life Sci (1969) 0.98
Pharmacokinetics of milnacipran in comparison with other antidepressants. Int Clin Psychopharmacol (1996) 0.98
Toxicity of antidepressants. Lancet (1986) 0.96
Changes in brain monoamine metabolism associated with CO2-induced amnesia in rats. Br J Pharmacol (1973) 0.95
Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol (1981) 0.94
The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. Pharmacopsychiatry (2006) 0.94
The effect of a new tetracyclic anti-depressant compound, Org GB 94, on the turnover of dopamine, noradrenalin and serotonin in the rat brain. Arch Int Pharmacodyn Ther (1973) 0.94
Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci (1999) 0.94
The effect of a tetracyclic antidepressant compound, Org GB94, on the turnover of biogenic amines in rat brain. Biochem Pharmacol (1976) 0.94
Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord (1994) 0.93
The acute effects of oestrogen and progesterone on the monoamine levels of the brain of ovariectomised rats. Psychopharmacologia (1971) 0.92
Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat. Immunopharmacology (1998) 0.92
An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats. Immunopharmacology (2000) 0.91
Neutrophil and monocyte phagocytosis in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry (1993) 0.91
Effect of four amphetamines on brain biogenic amines and their metabolites. Biochem Pharmacol (1972) 0.91
Beta-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation. Behav Brain Res (1998) 0.91
Forced swim test-induced neurochemical endocrine, and immune changes in the rat. Pharmacol Biochem Behav (1997) 0.90
Androgenic involvement in conditioned taste aversion. Horm Behav (1978) 0.89
Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action. Eur J Pharmacol (2000) 0.89
The effect of some hallucinogenic drugs on the amino acid precursors of brain monoamines. Life Sci I (1970) 0.88
Varying responses to the rat forced-swim test under diurnal and nocturnal conditions. Physiol Behav (2000) 0.88
Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats. Pharmacol Biochem Behav (1995) 0.88
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat. J Psychopharmacol (1997) 0.87
Effects of chronic (+/-)-propranolol on catecholamines and GABA in rat striatum [proceedings]. Br J Pharmacol (1977) 0.87
Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat. Pharmacol Biochem Behav (1999) 0.87
Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur J Pharmacol (1999) 0.86
Behavioural, biochemical and histological effects of trimethyltin (TMT) induced brain damage in the rat. Neurochem Int (1992) 0.86
Peripheral adrenoceptors and serotonin receptors in depression. Changes associated with response to treatment with trazodone or amitriptyline. J Affect Disord (1985) 0.86
Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients. Brain Behav Immun (2011) 0.86
BIMT 17: a putative antidepressant with a fast onset of action? Psychopharmacology (Berl) (1997) 0.86
Community-based exercise intervention: Zuni Diabetes Project. Diabetes Care (1988) 0.86
Effects of prior exposure on conditioned taste aversion in the rat: androgen- and estrogen-dependent events. J Comp Physiol Psychol (1979) 0.86
Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats. J Psychopharmacol (2007) 0.85
Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity. Eur Neuropsychopharmacol (1999) 0.85
Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacol Biochem Behav (2000) 0.85
Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635. J Psychopharmacol (1999) 0.84
Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor. Brain Res (1991) 0.84
Effect of chronic amphetamine administration on the behaviour of rats in the open field apparatus: reversal of post-withdrawal depression by two antidepressants. J Pharm Pharmacol (1978) 0.84
The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat. Eur Neuropsychopharmacol (1997) 0.84
Forced swim test-induced endocrine and immune changes in the rat: effect of subacute desipramine treatment. Pharmacol Biochem Behav (1998) 0.84
The effect of alpha-melanocyte stimulating hormone (alpha-msh) on the metabolism of biogenic amines in the rat brain. J Neurosci Res (1976) 0.83
Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat. Eur J Pharmacol (1999) 0.83
Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats. Mol Psychiatry (2004) 0.83
Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression. Br J Clin Pharmacol (1985) 0.83
Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment. Neuroimmunomodulation (2000) 0.83
Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge. Life Sci (2000) 0.83
Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat. Neuroimmunomodulation (1996) 0.82
Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression. Pharmacol Biochem Behav (1997) 0.82
Effects of Org 6582, chlorimipramine and desmethylimipramine on the depletion of biogenic amines from the rat brain in vivo. Biochem Pharmacol (1977) 0.82
Acute and chronic effects of 4-chloroamphetamine on monoamine metabolism in the rat brain. Psychopharmacologia (1976) 0.82
The effect of the chronic administration of D-amphetamine upon circadian changes in amino acids in the pineal and pituitary glands of the rat. J Neurosci Res (1975) 0.82
Proceedings: Variations in the concentrations of monamines and their metabolites in eight regions of rat brain during the oestrous cycle: a basis for interactions between hormones and psychotropic drugs. J Pharm Pharmacol (1975) 0.81
Changes in whole brain membranes of rats following pre- and post-natal exposure to ethanol. Alcohol Alcohol (1991) 0.81
An investigation of the antidepressant properties of lofepramine and its desmethylated metabolites in the forced swim and olfactory bulbectomized rat models of depression. Eur Neuropsychopharmacol (1999) 0.81
Modification by oestrogen of the effects of (D)-amphetamine sulphate on noradrenaline metabolism in discrete areas of rat brain[proceedings]. Br J Pharmacol (1976) 0.81
The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression. Brain Behav Immun (1996) 0.80
The effect of chronic administration of C-amphetamine on regional changes in catecholamines in the rat brain. J Neurosci Res (1977) 0.80
Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected? Eur J Pharmacol (1998) 0.80
The neuroprotective effect of tacrine on trimethyltin induced memory and muscarinic receptor dysfunction in the rat. Neurochem Int (1994) 0.80
Is ethanol a neurotoxin?: The effects of ethanol on neuronal structure and function. Alcohol Alcohol (1986) 0.80
The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology (1994) 0.80
The sigma ligand JO 1784 prevents trimethyltin-induced behavioural and sigma-receptor dysfunction in the rat. Pharmacol Toxicol (1996) 0.80
Effect of chronic pretreatment with the sigma ligand JO 1784 on CRF-induced changes in behaviour, neurotransmitter and immunological function in the rat. Neuropsychobiology (1997) 0.80
Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats. Brain Res (1997) 0.79
The effect of the chronic administration of barbitone sodium on pituitary-adrenal function in the rat. Biochem Pharmacol (1966) 0.79
A comparison of the psychopharmacological profiles of phencyclidine, ketamine and (+) SKF 10,047 in the trimethyltin rat model. Neuropharmacology (1990) 0.79
Acute toxicity profile of maprotiline in the rat. Pharmacol Toxicol (1999) 0.79
Some effects of mianserin on monoamine metabolism in the rat brain. Br J Clin Pharmacol (1978) 0.79
Metyrapone displays antidepressant-like properties in preclinical paradigms. Psychopharmacology (Berl) (1999) 0.79
Changes in muscarinic (M1 and M2 subtypes) and phencyclidine receptor density in the rat brain following trimethyltin intoxication. Neurochem Int (1994) 0.79
Beta-amyloid(1-42)-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex. Neurobiol Dis (2001) 0.79
Pharmacological strategies in the treatment of cerebral ischemia. Eur Neurol (1995) 0.79
GABA and gonadal hormones. Brain Res (1978) 0.78
Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam. Epilepsy Behav (2005) 0.78
Differential effect of a single high dose of the tricyclic antidepressant imipramine on interleukin-1beta and tumor necrosis factor-alpha secretion following an in vivo lipopolysaccharide challenge in rats. Int J Immunopharmacol (1999) 0.78
Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors. Arch Int Pharmacodyn Ther (1972) 0.78
The effect of D-amphetamine on the concentration of phospholipids in the rat hippocampus. Z Naturforsch C (1974) 0.78
Modulation of MK-801-induced behaviour by noradrenergic agents in mice. Psychopharmacology (Berl) (2001) 0.78
Variation in hydroxytryptamine metabolism in the rat: effects on the neurochemical response to phencyclidine. J Pharm Pharmacol (1971) 0.78
Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats. Life Sci (2001) 0.78